跳至主要内容
临床试验/JPRN-UMIN000007255
JPRN-UMIN000007255已完成未知

Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients. - Effect of DPP-4 inhibitor for coronary plaque in diabetes patients.

Center for Cardiovascular Interventions,Chiba University Hospital0 个研究点目标入组 128 人开始时间: 2012年2月9日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with severe coronary stenosis who are eligible for IVUS. 2)Acute myocardial infarction 3)Patients who have unprotected LMT lesion. 4)Severe renal disease or/and serum creatinine level>2.0mg/dl 5)Left ventricular ejection fraction=<40% 6)Type1 diabetes mellitus 7)Allergy for antiplatelet,anticoagulant drug,dipeptidyl-peptidase4 inhibitor and sulfonylureas 8)Severe liver dysfunction 9)Pregnancy 10)Other patients judged as being inappropriate for the subjects of the study by investigators.

研究者

发起方
Center for Cardiovascular Interventions,Chiba University Hospital

相似试验

Effect of DPP-4(dipeptidyl peptidase-4) inhibitor... | 临床试验